Difference between revisions of "Timeline of antibiotics"

From Timelines
Jump to: navigation, search
Line 50: Line 50:
 
|-
 
|-
 
| 1984 || || Antibiotic {{w|ampicillin/clavulanate}} is introduced.<ref name="Oxford Handbook of Infectious Diseases and Microbiology"/> ||
 
| 1984 || || Antibiotic {{w|ampicillin/clavulanate}} is introduced.<ref name="Oxford Handbook of Infectious Diseases and Microbiology"/> ||
 +
|-
 +
| 1985 || || Researchers at {{w|Eli Lilly and Company}} discover antibiotic {{w|daptomycin}}.<ref>{{cite book|title=Current Medical Research and Opinion, Volume 22, Issues 9-12|publisher=Clayton-Wray Publications Limited, 2006|url=https://books.google.com.ar/books?id=yqhNAQAAIAAJ&q=%22Daptomycin%22+%22in+1985..1990%22&dq=%22Daptomycin%22+%22in+1985..1990%22&hl=en&sa=X&ved=0ahUKEwjK4_3av5DaAhULiZAKHd3YBiAQ6AEIKDAA}}</ref><ref>{{cite journal|last1=Rybak|first1=M. J.|title=The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram‐positive bacteria|url=https://onlinelibrary.wiley.com/doi/full/10.1111/j.1469-0691.2006.01342.x}}</ref><ref>{{cite journal|last1=Beiras-Fernandez|first1=Andres|last2=Ferdinand Vogt|first2=Ferdinand Vogt|last3=Sodian|first3=Ralf|last4=Weis|first4=Florian|title=Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens|doi=10.2147/IDR.S6961|pmid=21694898|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108743/|pmc=3108743}}</ref> || {{w|United States}}
 
|-
 
|-
 
| 1987 || || Antibiotic {{w|imipenem/cilastin}} is introduced.<ref name="Oxford Handbook of Infectious Diseases and Microbiology"/>
 
| 1987 || || Antibiotic {{w|imipenem/cilastin}} is introduced.<ref name="Oxford Handbook of Infectious Diseases and Microbiology"/>

Revision as of 18:41, 28 March 2018

This is a timeline of FIXME.

Big picture

Time period Development summary More details

Full timeline

Year Event type Details Geographical location
1932 German pathologist Gerhard Domagk develops prontosil, the first sulphonamide microbial.[1][2][3] Germany
1942 Penicillin is introduced.[3]
1943 Streptomycin is introduced. It is the first antibiotic effective against tuberculosis.[4][5][6][3]
1945 The cephalosporins are discovered from a fungus, Cephalosporium acremonium, in seawater samples near a sewage outfall in Sardinia.[3][7][8][9] Italy
1947 Chloramphenicol is isolated from the soil organism Streptomyces venezuelae. Merketed in 1949, its use would quickly become widespread due to its broad spectrum of antimicrobial activity.[10][11][12][13]
1947 American plant physiologist Benjamin Minge Duggar isolates chlortetracycline from a Missouri River mud sample. It is the first tetracycline introduced.[14][15][16][17] United States
1949 Jewish-American biochemist Selman Waksman and Hubert A. Lechevalier first isolate neomycin, as aminoglycoside antibiotic found in many topical medications such as creams, ointments, and eyedrops.[18][19][20] United States
1952 Eli Lilly and Company introduces erythromycin, an antibiotic useful for the treatment of a number of bacterial infections, including respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis.[21][22][23] United States
1956 Research team at the Lilly Biological Laboratories in Indiana first isolates vancomycin from bacterium streplomyces orienlalis. Vancomycin is used as a treatment for complicated skin infections, bloodstream infections, endocarditis, bone and joint infections, and meningitis caused by methicillin-resistant staphylococcus aureus.[3][24][25][26] United States
1961 Antibiotic ampicillin is introduced. Within a short time it would become the drug of choice for treatment of Hemophilus influenzae meningitis.[27][28][29][3]
1963 Weinstein and his colleagues from the Schering Corporation describe the first isolation of the gentamicin complex.[3][30][31][32] United States
1965 Dicloxacillin is synthesized by Bayer.[33][34][35]
1966 Antibiotic doxycycline is introduced.[36][37][38][3]
1968 Antibiotic rifampicin is introduced for clinical use.[39][40][41] Italy
1970 Non-toxic semi-synthetic acid-resistant isoxazolyl penicillin flucloxacillin is introduced into clinical practice.[35][42]
1972 Antibiotic minocycline is discovered.[36][37][38]
1974 Antibiotic trimethoprim/sulfamethoxazole is commercially released.[43][3]
1976 Antibiotic amikacin is introduced.[3]
1984 Antibiotic ampicillin/clavulanate is introduced.[3]
1985 Researchers at Eli Lilly and Company discover antibiotic daptomycin.[44][45][46] United States
1987 Antibiotic imipenem/cilastin is introduced.[3]
1987 Antibiotic ciprofloxacin is introduced.[3]
1993 Antibiotics azithromycin and clarithromycin are introduced.[3]
1999 Antibiotic quinupristin/dalfopristin is introduced.[3]
2000 Antibiotic linezolid is introduced.[3]
2001 Antibiotic telithromycin is introduced in the European Union.[47][48][49]
2003 Antibiotic daptomycin is introduced.[3]
2005 Antibiotic tigecycline is introduced for the treatment of skin and skin structure infections and intraabdominal infections.[50][51][52]

Meta information on the timeline

How the timeline was built

The initial version of the timeline was written by FIXME.

Funding information for this timeline is available.

Feedback and comments

Feedback for the timeline can be provided at the following places:

  • FIXME

What the timeline is still missing

[1], [2]

Timeline update strategy

See also

External links

References

  1. ↑ Ravina, Enrique. The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. 
  2. ↑ Savona-Ventura, Charles. Contemporary Medicine in Malta [1798-1979]. 
  3. ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 3.16 Torok, Estee; Moran, Ed; Cooke, Fiona. Oxford Handbook of Infectious Diseases and Microbiology. 
  4. ↑ Lorian, Victor. Antibiotics in Laboratory Medicine. 
  5. ↑ Morabia, Alfredo. Enigmas of Health and Disease: How Epidemiology Helps Unravel Scientific Mysteries. 
  6. ↑ Cumo, Christopher Martin. The Ongoing Columbian Exchange: Stories of Biological and Economic Transfer in World History: Stories of Biological and Economic Transfer in World History. 
  7. ↑ Stephanie Watts; Faingold, Carl; Dunaway, George; Crespo, Lynn. Brody's Human Pharmacology - E-Book. 
  8. ↑ Riviere, Jim E.; Papich, Mark G. Veterinary Pharmacology and Therapeutics. 
  9. ↑ Bennett, Peter N.; Brown, Morris J. Clinical Pharmacology E-Book: With STUDENTCONSULT Access. 
  10. ↑ Kacew, Sam. Drug Toxicity and Metabolism in Pediatrics. 
  11. ↑ Riviere, Jim E.; Papich, Mark G. Veterinary Pharmacology and Therapeutics. 
  12. ↑ Shapiro, Stuart. Regulation of Secondary Metabolism in Actinomycetes. 
  13. ↑ Aschenbrenner, Diane S.; Venable, Samantha J. Drug Therapy in Nursing. 
  14. ↑ Dougherty, Thomas J.; Pucci, Michael J. Antibiotic Discovery and Development. 
  15. ↑ Kokate, Chandrakant; Jalalpure, SS; Pramod, H.J. Textbook of Pharmaceutical Biotechnology - E-Book. 
  16. ↑ Advances in Pharmacology and Chemotherapy. 
  17. ↑ McKenna, John. Natural Alternatives to Antibiotics – Revised and Updated: How to treat infections without antibiotics. 
  18. ↑ Schindel, Leo. Unexpected Reactions to Modern Therapeutics: Antibiotics. 
  19. ↑ Grayson, M Lindsay; Crowe, Suzanne M; McCarthy, James S; Mills, John; Mouton, Johan W; Norrby, S Ragnar; Paterson, David L; Pfaller, Michael A. Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. 
  20. ↑ Advances in Carbohydrate Chemistry, Volume 18. 
  21. ↑ Rubin, Bruce K.; Tamaoki, Jun. Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. 
  22. ↑ Piscitelli, Stephen C.; Rodvold, Keith A.; Pai, Manjunath P. Drug Interactions in Infectious Diseases. 
  23. ↑ Nightingale; Mur. Antimicrobial Pharmacodynamics in Theory and Clinical Practice, Second Edition. 
  24. ↑ Staphylococci in Human Disease (Kent B. Crossley, Kimberly K. Jefferson, Gordon L. Archer, Vance G. Fowler ed.). 
  25. ↑ Antibiotics Annual. 
  26. ↑ Hejzlar, Miroslav. Advances in Antimicrobial and Antineoplastic Chemotherapy: Progress in Research and Clinical Application: pt. 1-2. Antimicrobial chemotherapy. 
  27. ↑ Atta-ur-Rahman. Studies in Natural Products Chemistry, Volume 56. 
  28. ↑ Thompson, R.A.; Green, John R. Infectious Diseases of the Central Nervous System. 
  29. ↑ Fifty Years of Antimicrobials: Past Perspectives and Future Trends. Society for General Microbiology. Symposium. 
  30. ↑ Advances in Applied Microbiology, Volume 18. 
  31. ↑ Eardley, Ian; Whelan, Peter; Kirby, Roger; Schaeffer, Anthony. Drug Treatment in Urology. 
  32. ↑ Antimicrobials: Synthetic and Natural Compounds (Dharumadurai Dhanasekaran, Nooruddin Thajuddin, A. Panneerselvam ed.). 
  33. ↑ McGuire, John L. Pharmaceuticals, 4 Volume Set. 
  34. ↑ Kuemmerle, Helmut Paul. Clinical Chemotherapy: Antimicrobial Chemotherapy. 
  35. ↑ 35.0 35.1 Harper, N. J.; Simmonds, Alma B. Advances in Drug Research, Volume 7. 
  36. ↑ 36.0 36.1 Yaffe, Sumner J.; Aranda, Jacob V. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. 
  37. ↑ 37.0 37.1 Denyer, Stephen P.; Hodges, Norman A.; Gorman, Sean P.; Gilmore, Brendan F. Hugo and Russell's Pharmaceutical Microbiology. 
  38. ↑ 38.0 38.1 Dirnagl, Ulrich; Elger, Bernd. Neuroinflammation in Stroke. 
  39. ↑ Rahman, Atta -ur-; Choudhary, M. Iqbal. Frontiers in Anti-Infective Drug Discovery, Volume 6. 
  40. ↑ Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set (y M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson ed.). 
  41. ↑ Mann, R.D. Modern Drug use: An Enquiry on Historical Principles. 
  42. ↑ Neonatal Formulary. BMJ Books, 2000. 
  43. ↑ "Pharmaceutical Marketing in India". books.google.com.ar. Retrieved 28 March 2018. 
  44. ↑ Current Medical Research and Opinion, Volume 22, Issues 9-12. Clayton-Wray Publications Limited, 2006. 
  45. ↑ Rybak, M. J. "The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram‐positive bacteria". 
  46. ↑ Beiras-Fernandez, Andres; Ferdinand Vogt, Ferdinand Vogt; Sodian, Ralf; Weis, Florian. "Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens". PMC 3108743Freely accessible. PMID 21694898. doi:10.2147/IDR.S6961. 
  47. ↑ Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition - Three Volume Set (M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson ed.). 
  48. ↑ Alex, Alexander; Harris, C. John; Smith, Dennis A. Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward. 
  49. ↑ Hugo and Russell's Pharmaceutical Microbiology (Stephen P. Denyer, Norman A. Hodges, Sean P. Gorman, Brendan F. Gilmore ed.). 
  50. ↑ Low-dose antibiotics: current status and outlook for the future (Robert Paul Hunter, Carlos F Amábile-Cuevas, Jun Lin, Joshua D Nosanchuk, Rustam Aminov ed.). 
  51. ↑ Vincent, Jean-Louis; Abraham, Edward; Kochanek, Patrick; Moore, Frederick A.; Fink, Mitchell P. Textbook of Critical Care E-Book. 
  52. ↑ Trauma: Critical Care (William C. Wilson, Christopher M. Grande, David B. Hoyt ed.). 
Retrieved from "http://timelines.issarice.com/index.php?title=Timeline_of_antibiotics&oldid=21247"